Home › Major Depressive Disorder › Florida › Orlando

Pag-aaral pangklinika para sa Major Depressive Disorder sa Orlando, FL

19 pag-aaral para sa Major Depressive Disorder ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Orlando (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

Nagre-recruitPhase 3

Nova Psychiatry INC, Orlando

Edad 18 hanggang 74 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06559306

A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)

Nagre-recruitPhase 2

Clinical Neuroscience Solutions Inc. - Orlando, Orlando
K2 Medical Research - Maitland, Maitland · 6 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07621237

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

Nagre-recruitPhase 3

Accel Research Sites - Maitland, Maitland · 6 mi ang layo

Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06793397

A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)

Nagre-recruitPhase 2

Seaport Investigator Site, Orlando

Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 14, 2026 · NCT07065240

ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response

Nagre-recruitPhase 2

Clinical Neuroscience Solutions, Inc., Orlando

Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 14, 2026 · NCT07284667

A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression

Nagre-recruitPhase 2

Draig Clinical Site, Orlando
Draig Clinical Site, Orlando

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 2, 2026 · NCT07610473

A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression

Nagre-recruitPhase 2

Draig Clinical Site, Orlando

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Ago 26, 2026 · NCT07300969

A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)

Nagre-recruitPhase 3

Clinical Neuroscience Solutions, LLC (Orlando), Orlando
Charter Research, Orlando
K2 Medical Research (Maitland), Maitland · 6 mi ang layo

Edad 18 hanggang 74 · Lahat ng kasarian · Na-update Ago 10, 2026 · NCT07592689

NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Nagre-recruitPhase 3

Neurocrine Clinical Site, Maitland · 6 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 10, 2026 · NCT06963021

A Study of Brenipatide in Adult Participants With Major Depressive Disorder

Nagre-recruitPhase 3

Charter Research - Orlando, Orlando
K2 Medical Research - Maitland, Maitland · 6 mi ang layo

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT07412756

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

Nagre-recruitPhase 3

Clinical Neuroscience Solutions, Inc., Orlando

Edad 18 hanggang 74 · Lahat ng kasarian · Na-update Ago 3, 2026 · NCT06775379

Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

Nagre-recruitPhase 2

Clinical Neuroscience Solutions, Inc., Orlando

Edad 18 hanggang 64 · Lahat ng kasarian · Na-update Ago 3, 2026 · NCT06547489

A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Nagre-recruitPhase 3

Neurocrine Clinical Site, Orlando

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 24, 2026 · NCT07196501

Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Nagre-recruitPhase 3

Neurocrine Clinical Site, Maitland · 6 mi ang layo
Neurocrine Clinical Site, Maitland · 6 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 24, 2026 · NCT06966401

A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder

Nagre-recruitPhase 2

Clinical Neuroscience Solutions - Orlando - East South Street /ID# 277558, Orlando

Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Hun 15, 2026 · NCT07276997

Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Nagre-recruitPhase 3

Neurocrine Clinical Site, Maitland · 6 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 29, 2025 · NCT06786624

Targeting Network Dysfunction in Apathy of Late-life Depression Using Digital Therapeutics

Nagre-recruit

AdventHealth Neuroscience Institute, Orlando

Edad 60 pataas · Lahat ng kasarian · Na-update Okt 22, 2025 · NCT05877885

Study of ALTO-300 in MDD

Nagre-recruitPhase 2

Site 159, Clermont · 24 mi ang layo

Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Hul 24, 2025 · NCT05922878

A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms

Nagre-recruitPhase 4

Clinical Research Site, Orlando
Clinical Research Site, Orlando
Clinical Research Site, Orlando

Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Ene 23, 2025 · NCT06223880

Pag-aaral para sa Major Depressive Disorder sa ibang lungsod

Iba pang pag-aaral sa Orlando

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.